• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Manitowoc, Helix Energy Solutions, JELD-WEN Holding And Other Big Stocks Moving Higher On Tuesday

    2/21/23 10:38:48 AM ET
    $APLS
    $AY
    $DDL
    $HLX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Electric Utilities: Central
    Utilities
    Get the next $APLS alert in real time by email

    U.S. stocks traded lower, with the Dow Jones dropping around 450 points on Tuesday. Here are some big stocks recording gains in today’s session.

    • LanzaTech Global, Inc. (NASDAQ:LNZA) jumped 27.7% to $5.30.
    • Helix Energy Solutions Group, Inc. (NYSE:HLX) climbed 17.7% to $8.98 after the company posted a profit for the fourth quarter.
    • Procaps Group S.A. (NASDAQ:PROC) gained 14% to $4.72.
    • Travere Therapeutics, Inc. (NASDAQ:TVTX) climbed 13.6% to $20.24. The FDA granted accelerated approval to Travere Therapeutics’ Filspari (sparsentan) to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.
    • Sigma Lithium Corporation (NASDAQ:SGML) jumped 13.1% to $33.34 following reports that Tesla is considering a bid for the battery metals mining company.
    • Dingdong (Cayman) Limited (NYSE:DDL) rose 12.2% to $5.07.
    • The Manitowoc Company, Inc. (NYSE:MTW) surged 11.8% to $16.06 after reporting Q4 results.
    • Apellis Pharmaceuticals Inc (NASDAQ:APLS) shares gained 11.4% to $61.96 after the company said that the FDA approved SYFOVRE as first and only treatment for geographic atrophy.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) climbed 10.2% to $28.67.
    • Vir Biotechnology, Inc. (NASDAQ:VIR) rose 9.8% to $28.27 after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $41 to $53.
    • Iris Acquisition Corp (NASDAQ:IRAA) gained 9.5% to $11.02.
    • HomeTrust Bancshares, Inc. (NASDAQ:HTBI) surged 7.9% to $30.30. Janney Montgomery Scott upgraded HomeTrust Bancshares from Neutral to Buy.
    • Atlantica Sustainable Infrastructure plc (NASDAQ:AY) jumped 7.7% to $27.91.
    • JELD-WEN Holding, Inc. (NYSE:JELD) gained 7% to $13.77 following better-than-expected quarterly earnings.
    • MVB Financial Corp. (NASDAQ:MVBF) gained 6.8% to $25.83. MVB Financial, on Friday, posted Q4 EPS of $0.50.

    Check This Out: Ethereum Falls But Remains Above $1,600; Blur, Filecoin Among Top Losers

    Get the next $APLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APLS
    $AY
    $DDL
    $HLX

    CompanyDatePrice TargetRatingAnalyst
    Apellis Pharmaceuticals Inc.
    $APLS
    3/13/2026$31.00Buy
    Roth Capital
    Vir Biotechnology Inc.
    $VIR
    2/24/2026$19.00Outperform → Strong Buy
    Raymond James
    MVB Financial Corp.
    $MVBF
    2/13/2026$31.00 → $33.00Outperform
    Hovde Group
    Sigma Lithium Corporation
    $SGML
    2/3/2026$14.00Underperform → Neutral
    BofA Securities
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    Sigma Lithium Corporation
    $SGML
    1/23/2026Hold → Buy
    Canaccord Genuity
    Apellis Pharmaceuticals Inc.
    $APLS
    1/21/2026$28.00Neutral → Buy
    BofA Securities
    Sigma Lithium Corporation
    $SGML
    1/16/2026Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $APLS
    $AY
    $DDL
    $HLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLS
    $AY
    $DDL
    $HLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dingdong (Cayman) Limited Announces Results of 2026 Annual General Meeting

    SHANGHAI, March 27, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE:DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that each of the proposed resolutions submitted for shareholders' approval as set forth in the notice of annual general meeting dated March 10, 2026 has been adopted at its 2026 annual general meeting of shareholders held in Shanghai, China today. About Dingdong (Cayman) LimitedWe are a leading fresh grocery e-commerce company in mainland China, with sustainable long-term growth. We directly provide users and households with fresh groceries, prepared food, and other food produ

    3/27/26 9:00:00 AM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary

    Banking Virtual Investor Conference: Presentations Now Available for Online Viewing

    NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced presentations from the March 26th Banking Virtual Investor Conference are available for on-demand viewing. The event featured presentations and live Q&A sessions with executives from regional and community banking institutions across the United States, along with a keynote presentation, "The Community Bank Paradox: Why Banks That Value Shareholders Most Often Serve Them Least," delivered by Kara Kennedy of ClearTrust LLC. Investors, advisors, and analysts can now access presentations at their convenience. REGISTER AND VIEW PRESENTATIONS HERE The

    3/27/26 8:35:00 AM ET
    $MVBF
    Major Banks
    Finance

    Banking Virtual Investor Conference Agenda Announced for March 26th

    NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Banking Virtual Investor Conference to be held March 26, 2026. The event will feature presentations and live Q&A sessions from executives of regional & community banking institutions across the United States. Participating companies will provide insights into their growth strategies, lending environments, and regional market opportunities. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE It is recommended that investors pre-register and run the online system check to ex

    3/24/26 7:53:10 AM ET
    $MVBF
    Major Banks
    Finance

    $APLS
    $AY
    $DDL
    $HLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on Apellis Pharmaceuticals with a new price target

    Roth Capital initiated coverage of Apellis Pharmaceuticals with a rating of Buy and set a new price target of $31.00

    3/13/26 8:46:55 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vir Biotechnology upgraded by Raymond James with a new price target

    Raymond James upgraded Vir Biotechnology from Outperform to Strong Buy and set a new price target of $19.00

    2/24/26 7:40:37 AM ET
    $VIR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Hovde Group reiterated coverage on MVB Financial with a new price target

    Hovde Group reiterated coverage of MVB Financial with a rating of Outperform and set a new price target of $33.00 from $31.00 previously

    2/13/26 7:59:44 AM ET
    $MVBF
    Major Banks
    Finance

    $APLS
    $AY
    $DDL
    $HLX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Vir Biotechnology Inc.

    SCHEDULE 13G/A - Vir Biotechnology, Inc. (0001706431) (Subject)

    3/27/26 1:55:01 PM ET
    $VIR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Travere Therapeutics Inc.

    SCHEDULE 13G/A - Travere Therapeutics, Inc. (0001438533) (Subject)

    3/27/26 1:33:33 PM ET
    $TVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by MVB Financial Corp.

    SCHEDULE 13G/A - MVB FINANCIAL CORP (0001277902) (Subject)

    3/27/26 10:48:31 AM ET
    $MVBF
    Major Banks
    Finance

    $APLS
    $AY
    $DDL
    $HLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Guardians Of New Zealand Superannuation bought $4,300,000 worth of shares (969,858 units at $4.43), increasing direct ownership by 292% to 1,302,492 units (SEC Form 4)

    4 - LanzaTech Global, Inc. (0001843724) (Issuer)

    2/18/26 8:17:53 PM ET
    $LNZA
    Major Chemicals
    Industrials

    Director Cordella Richard James Jr bought $13,850 worth of Common Stock (500 units at $27.70) (SEC Form 4)

    4 - MVB FINANCIAL CORP (0001277902) (Issuer)

    12/8/25 11:04:59 AM ET
    $MVBF
    Major Banks
    Finance

    Chief Financial Officer Sumbs Michael Robert bought $52,000 worth of Common Stock (2,000 units at $26.00) (SEC Form 4)

    4 - MVB FINANCIAL CORP (0001277902) (Issuer)

    11/5/25 3:16:16 PM ET
    $MVBF
    Major Banks
    Finance

    $APLS
    $AY
    $DDL
    $HLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sabatini Brent

    4 - Vir Biotechnology, Inc. (0001706431) (Issuer)

    3/24/26 4:35:36 PM ET
    $VIR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by O'Byrne Jason

    4 - Vir Biotechnology, Inc. (0001706431) (Issuer)

    3/23/26 3:49:52 PM ET
    $VIR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Reed Elizabeth E

    4 - Travere Therapeutics, Inc. (0001438533) (Issuer)

    3/18/26 4:05:31 PM ET
    $TVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLS
    $AY
    $DDL
    $HLX
    Leadership Updates

    Live Leadership Updates

    View All

    Dingdong Announces Change in CEO

    SHANGHAI, March 4, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced the resignation of Mr. Changlin Liang as Chief Executive Officer of the Company and the appointment of Mr. Song Wang as the new Chief Executive Officer of the Company, concurrently with his resignation as Chief Financial Officer, effective March 4, 2026. Mr. Liang will continue to serve as Chairman of the Company's Board of Directors (the "Board"). As the founder of the Company, Mr. Liang has served as Chairman of the Board and Chief Executive Officer since the inception of th

    3/4/26 6:00:00 AM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary

    Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors

    WALTHAM, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced today that Mikael Dolsten, M.D., Ph.D., has joined the company's board of directors as of March 1. Most recently, Dr. Dolsten served for more than 16 years as chief scientific officer and president, worldwide research, development and medical, at Pfizer, during which he presided over the regulatory approval of more than 36 medicines and vaccines.  "We are thrilled to welcome Mikael to the Apellis Board of Directors," said Cedric Francois, M.D., Ph.D., chief executive officer and co-founder, Apellis. "Mikael is a proven industry leader with deep experience developing innovative medicine

    3/2/26 7:00:00 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MVB Financial Names Dr. Kelly Nelson Chairman of the Board of Directors; Appoints Adam Famularo New Director

    The Board of Directors of MVB Financial Corp. ("MVBF" or "MVB Financial") (NASDAQ:MVBF), today announced that Dr. Kelly R. Nelson has been named Chairman of the Board and announced the appointment of Adam Famularo as a Member of the Board, effective February 17, 2026. Dr. Nelson Assumes Chairman Role Dr. Nelson, who has been a member of the Board since 2004, replaces retiring Chairman W. Marston "Marty" Becker. "Dr. Nelson brings a combination of medical expertise, business acumen and deep community commitment to his new role as Chairman," said Larry F. Mazza, CEO and President, MVB Financial. "His experience makes him uniquely suited for this leadership role. Dr. Nelson previously ch

    2/18/26 4:30:00 PM ET
    $MVBF
    Major Banks
    Finance

    $APLS
    $AY
    $DDL
    $HLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Atlantica Sustainable Infrastructure plc

    SC 13D/A - Atlantica Sustainable Infrastructure plc (0001601072) (Subject)

    12/12/24 12:30:42 PM ET
    $AY
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SC 13D/A filed by Procaps Group S.A.

    SC 13D/A - Procaps Group, S.A. (0001863362) (Subject)

    12/3/24 7:20:10 PM ET
    $PROC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLS
    $AY
    $DDL
    $HLX
    Financials

    Live finance-specific insights

    View All

    Dingdong (Cayman) Limited to Hold 2026 Annual General Meeting of Shareholders on March 27, 2026

    SHANGHAI, March 10, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited (the "Company") (NYSE:DDL), a leading fresh grocery e-commerce company in China, today announced that it will hold the 2026 annual general meeting of shareholders (the "AGM") at Building T4, Zhangjiang Science Gate, Lane 188 Yuren Road, Pudong District, Shanghai 201210, People's Republic of China on March 27, 2026 at 8:00 PM Shanghai time. The purpose of the AGM is for the Company's shareholders to consider and, if thought fit, pass each of the proposed resolutions set forth in the notice of the AGM (the "AGM Notice"). The AGM Notice, which contains detailed proposals and additional information regarding the AGM, and the form

    3/10/26 7:00:00 AM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary

    Dingdong to Report Fourth Quarter 2025 Financial Results on March 4, 2026

    SHANGHAI, March 2, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that it will report its unaudited financial results for the fourth quarter ended December 31, 2025, before U.S. markets open on March 4, 2026. About Dingdong (Cayman) Limited Dingdong is the leading fresh grocery e-commerce company in mainland China, with sustainable long-term growth. The Company directly provides users and households with fresh groceries, prepared food, and other food products through delivering a convenient and excellent shopping experience supported by an e

    3/2/26 6:00:00 AM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary

    Record Date for 2026 Annual General Meeting of Shareholders

    SHANGHAI, Feb. 25, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited (the "Company") (NYSE:DDL), a leading fresh grocery e-commerce company in China, announces that the record date for the purpose of determining the eligibility of the holders of the Class A ordinary shares and the Class B ordinary shares of the Company, par value US$ 0.000002 each (the "Ordinary Shares"), to vote and attend the forthcoming 2026 annual general meeting of the Company (the "AGM"), will be as of the close of business on Monday, March 9, 2026, Shanghai time (the "Ordinary Share Record Date"). In order to be eligible to vote and attend the AGM, with respect to Ordinary Shares registered on the Company's principal sha

    2/25/26 11:30:00 PM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary